Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK/PD of HemaMax in healthy subjects
NCT02343133Phase 2Completed
- Sponsor
- Neumedicines Inc.
- Start
- Jan 2015
- Primary completion
- Apr 2016
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of HemaMax in Acute Radiation Syndrome (ARS), sponsored by Neumedicines Inc.. Started Jan 2015; status: completed.
02
Drugs
HemaMax
03
Conditions
Acute Radiation Syndrome (ARS)
Beyond the preview
Go deeper on NCT02343133.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02343133.